Selling a new Web-connected thermostat or other wired gizmo to consumers without a plan to deliver the necessary security patches is not only bad business—it’s unethical. So is failing to challenge a law or tech company rule that governs work on... Read more »
Cyber breaches caused by people within businesses and organizations, both accidental and malicious leaks, continue to multiply. Now, a Boston security startup is arming itself with more cash and enhanced technology to try and stop these insider threats.
ObserveIT announced... Read more »
Michigan’s government and business leaders have worked diligently over the past few years to position the state that put the world on wheels to be major player in the development of self-driving cars. (According to a June 25 opinion piece in... Read more »
In real estate, location is key. The same holds true in the hunt for new drugs. HotSpot Therapeutics is trying to break new ground in drug discovery by hitting locations on a protein that aren’t the conventional targets of most medicines.... Read more »
[Updated 7/17/18, 11:26 am, with English’s comments. See below.] Lola, the business travel software startup led by Kayak co-founder Paul English, has brought on a new chief executive: Mike Volpe, the former chief marketing officer at both HubSpot and... Read more »
[Updated 7/16/18 4:00pm ET, see note below] As CRISPR-based therapeutics inch closer to human tests in the U.S., academic researchers have kept up a steady drum beat about potential risks of the gene editing technique. They recently published two... Read more »
The cause of fibrosis, the hardening and thickening of connective tissue in organs, isn’t known and it has few treatments. Pliant Therapeutics aims to bring patients who have this chronic and life-threatening condition in the lungs or the liver a new... Read more »
More than a year after the FDA rejected Amgen’s experimental osteoporosis drug due to safety concerns, the Thousand Oaks, CA, company has teed up a new application.
The Amgen (NASDAQ: AMGN) drug, romosozumab (Evenity), is an antibody treatment meant... Read more »
Humans have had a drastic physical evolution recently—one that has notably taken only a few years. While the evolution from hunched primates to homo sapiens took tens of millions of years, we needed only about a decade to develop an arched... Read more »
It’s time to catch up on Boston tech headlines. This week, we’re tracking acquisitions by Autodesk and DataRobot, a $100 million investment in upstart wireless Internet provider Starry, a new startup from Runkeeper co-founder Jason Jacobs, details about a stealthy autonomous... Read more »
Drug price changes typically happen either at the start of the calendar year or the beginning of the third quarter. Such changes are routine for many companies, but Pfizer took an unusual step this week by rolling back scheduled price increases... Read more »
Semiconductor maker Broadcom, which ended its effort to buy competitor Qualcomm earlier this year, has a new target: New York-based business software maker CA Technologies.
The pair announced Wednesday that Broadcom (NASDAQ: AVGO), which moved its headquarters from Singapore... Read more »
In a sea of emerging tech venture funds, Glasswing Ventures is trying to stand out. The Boston firm announced today it has closed its debut investment fund at $112 million.
That’s bigger than the “micro-VC” funds of the past decade, but... Read more »